A group of North Korean tuberculosis patients stand in front of packages of medicine used to treat drug-resistant TB at a clinic in the southwest of the country. This month, an international fund announced it was ending grants for TB treatment in North Korea. That decision could add to the challenges faced by NGOs such as the Eugene Bell Foundation, which works in North Korea to treat drug-resistant TB.
A group of North Korean tuberculosis patients stand in front of packages of medicine used to treat drug-resistant TB at a clinic in the southwest of the country. This month, an international fund announced it was ending grants for TB treatment in North Korea. That decision could add to the challenges faced by NGOs such as the Eugene Bell Foundation, which works in North Korea to treat drug-resistant TB. Eugene Bell Foundation
A group of North Korean tuberculosis patients stand in front of packages of medicine used to treat drug-resistant TB at a clinic in the southwest of the country. This month, an international fund announced it was ending grants for TB treatment in North Korea. That decision could add to the challenges faced by NGOs such as the Eugene Bell Foundation, which works in North Korea to treat drug-resistant TB. Eugene Bell Foundation